Public Health | October 29, 2021
Mandaviya launches the sixth edition of National Formulary of India (NFI)
The NFI is published to promote the rational use of medicines in the country.
The NFI is published to promote the rational use of medicines in the country.
The youngest child in India to survive ECMO after undergoing bone marrow transplant for a rare disease
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
The list of kids with co-morbidities eligible for vaccination would be announced by the government
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
The authority also allowed mix and match of booster doses once the primary vaccine has been administered.
Second interchangeable biosimilar product approved by agency
The panel concurred that these supplements resolved post-Covid-19 fatigue and muscle weakness
U.S. FDA to decide whether to authorize a booster dose in the coming days
Subscribe To Our Newsletter & Stay Updated
